PT  - JOURNAL ARTICLE
AU  - Corr, Bradley
AU  - Cosgrove, Casey
AU  - Spinosa, Daniel
AU  - Guntupalli, Saketh
TI  - Endometrial cancer: molecular classification and future treatments
AID  - 10.1136/bmjmed-2022-000152
DP  - 2022 Oct 01
TA  - BMJ Medicine
PG  - e000152
VI  - 1
IP  - 1
4099  - http://bmjmedicine.bmj.com/content/1/1/e000152.short
4100  - http://bmjmedicine.bmj.com/content/1/1/e000152.full
SO  - bmjmed2022 Oct 01; 1
AB  - The treatment for endometrial cancer is rapidly evolving with the development of molecular analysis and novel strategies. Surgical resection, cytotoxic chemotherapy, endocrine or hormonal treatment, and radiation have been the staples of treatment for decades. However, precision based approaches for tumours are rapidly becoming a part of these strategies. Biomarker driven treatments are now a part of primary and recurrent treatment algorithms. This review aims to describe the current state of molecular analysis and treatment for endometrial cancer as well as to elucidate potential approaches for the near future.